Coloplast A/S (CPH:COLO.B)
Denmark · Delayed Price · Currency is DKK 546.40
+2.40 (0.44%)
At close: Dec 30, 2025
Coloplast Market Cap
Coloplast has a market cap or net worth of 123.14 billion as of December 31, 2025. Its market cap has decreased by -35.10% in one year.
Market Cap
123.14B
Enterprise Value
144.83B
Revenue
27.87B
Ranking
n/a
PE Ratio
33.87
Stock Price
546.40
Market Cap Chart
Since November 17, 1997, Coloplast's market cap has increased from 5.88B to 123.14B, an increase of 1,994.22%. That is a compound annual growth rate of 11.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 123.14B | -30.43% |
| Dec 30, 2024 | 177.00B | 2.05% |
| Dec 29, 2023 | 173.44B | 0.54% |
| Dec 30, 2022 | 172.51B | -29.57% |
| Dec 30, 2021 | 244.93B | 23.89% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.45T |
| Genmab | 124.86B |
| ALK-Abelló | 50.52B |
| Demant | 45.84B |
| H. Lundbeck | 41.40B |
| Zealand Pharma | 32.85B |
| Ambu A/S | 23.42B |
| GN Store Nord | 15.59B |